Haematology Chemotherapy Protocols
Disclaimer:
The chemotherapy protocols available on this website are maintained by the Lancashire and South Cumbria Network Pharmacist David Barber. The Cancer Alliance is not responsible for the content or upkeep of the protocols. If you have any queries about the protocols please contact David Barber: Tel 01772 522339 or david.barber@lthtr.nhs.uk
Amyloidosis: Regimens for treating amyloidosis can be found on the National Amyloidosis Centre website
Protocols A-G
ABVD July 2019
Acalabrutinib-CLL-MPM-Oct22
Alemtuzumab v2
Ara C low dose v2
ATG
ATRA Arsenic
Azacitidine 5 day protocol (unlicensed) v1.0 2021-05-12
Azacitidine v2
BEACOPP escalated 2014
Benda R NHL
Bendamustine Thalidomide Dexamethasone
Bortezomib dexamethasone v2
Bosutinib
Brentuximab
Busulphan v2
C-Thal Dex Att v2
C-Thal Dex v2
Carfilzomib dexamethasone
Chlorambucil v2
ChlVPP v2
Cladribine-Revised v2
CyBorDex
Cyclo 1.5
Cyclo 3.0
Cyclo weekly v2
Dara-VTD for newly diagnosed myeloma eligible for PBSCT Feb 2022
Daratumumab
Dasatinib v2
DECC
Dexamethasone high dose v2
DexRC3
DT PACE 2
DVd protocol Final
EPOCH R
Etoposide 2
FC CLL4 v2
FC LY05 v2
FC R v2
Fludara v2
GDCVP v1
Gem Cis Dex
GEM-P
Gemcitabine v2
Protocols H-N
Hodgkins-MPM-Mar18
Hydroxycarbamide v2
Ibrutinib CLL
Ibrutinib MCL
Ibrutinib plus venetoclax regimen FLAIR trial version 4 protocol draft
Idarubicin dexamethasone Oct 2022
Idelalisib Rituximab v2
Imatinib v2
Ixazomib Lenalidomide & Dexamethasone
Lenalidomide dexamethasone for myeloma
Lenalidomide for MDS
Lenalidomide Rituximab (Subcut) v1 2020-07-16
MATRIX v4
Melphalan and Predisolone
Melphalan v2
Methotrexate High Dose
Methylprednisolone HD v2
Modified R-CHOP-like Chemotherapy
MRCHOP
MTP
Myeloma guideline draft for Network 2018 UPDATE
Nilotinib v2
Nivolumab July 2024
NORDIC v2
Protocols O-Z
Cyclophos oral AIHA June 2021
Obinutuzumab and Bendamustine v1 - 2019-05
Obinutuzumab Chlorambucil
Obinutuzumab CVP
oral weekly mtx for CTCL December 2021
PAD bolus
Panobinostat Bortezomib Dexamethasone
PCNSDLBCL-Nov18
Pentostatin 2
Pixantrone
Polatuzumab_Rituximab_Bendamustine
Pomalidomide
Ponatinib
R-BAC(500)
R-BAC(800)
R-CODOX-M-over 65 v2
R-CODOX-M-under 65 v2
R-CVP 2
R-DHAP
R-ICE Fractionated
R-ICE v2
R-IVAC-over 65
R-IVAC-under 65 v2
RCD
RCDa
RCHOP-14 v2
RCHOP-21 v2
RGCVP v1
Ritux + cladribine for relapsed HCL v2 2022-01-05
Rituximab Bendamustine CLL
Rituximab Chlorambucil CLL
Rituximab Chlorambucil NHL
Rituximab Gemcitabine v1
Rituximab Jan 2021
Rituximab Subcutaneous (Mabthera) Maintenance
Rituximab Vel dex subcutaneous
Rituximab Venetoclax
Rsquared-Jan19-MPM
Ruxolitinib
Spanish AIDA
Temzolomide_NHL
Thalidomide v2
UKALL 14 Maintenance
VCD sc
VCD v2
VCD weekly
Vel dex SUBCUTANEOUS
Venetoclax
VEPEM-B v2
VMP v1
VRCAP
VTD 3 weekly v2
VTD 4 weekly
VTD weekly
Zanubrutinib-WM-MPM-Oct22